awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37791429-023B13C5-3252-44FC-86A3-77ABC6A59EFD
Q37791429-023B13C5-3252-44FC-86A3-77ABC6A59EFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37791429-023B13C5-3252-44FC-86A3-77ABC6A59EFD
Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.
P2860
Q37791429-023B13C5-3252-44FC-86A3-77ABC6A59EFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37791429-023B13C5-3252-44FC-86A3-77ABC6A59EFD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a65d6ba83e6deb7e546c29ce0521efa3261f6762
P2860
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.